Contact
searchSearch
HMP Global

Renal Denervation Topic Center

Featured

RDN & REIMBURSEMENT
Renal Denervation in Practice: A Conversation With Tai Kobayashi, MD
12/15/2025
Taisei J. Kobayashi, MD
"With CMS coverage finalized and private payers beginning to follow, renal denervation is poised to move from niche to mainstream," says Dr. Kobayashi. "The therapy’s safety profile is well established,(3,8) and now we have the infrastructure...
"With CMS coverage finalized and private payers beginning to follow, renal denervation is poised to move from niche to mainstream," says Dr. Kobayashi. "The therapy’s safety profile is well established,(3,8) and now we have the infrastructure...
"With CMS coverage finalized and...
12/15/2025
Cath Lab Digest
ultrasound renal denervation
Latest Real-World Clinical Data Demonstrate a 19.6 mmHg Reduction in Blood Pressure at 6 Months with Recor Medical’s Paradise Ultrasound Renal Denervation System
10/30/2025
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE Clinical Trial Program Demonstrates a 15.7...
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE Clinical Trial Program Demonstrates a 15.7...
Data Presented at the 2025 TCT...
10/30/2025
Cath Lab Digest
Renal Denervation
CMS Issues National Coverage Determination for Recor Medical’s Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
10/29/2025
Recor Medical, Inc., News Palo Alto, Calif. – Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that the Centers for Medicare and Medicaid Services (CMS) has issued its National Coverage...
Recor Medical, Inc., News Palo Alto, Calif. – Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that the Centers for Medicare and Medicaid Services (CMS) has issued its National Coverage...
Recor Medical, Inc.,...
10/29/2025
Cath Lab Digest
Resistant Hypertension
Paradise™ Ultrasound Renal Denervation in Contemporary Practice
10/03/2025
Behnam N. Tehrani, MD, FSCAI
"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...
"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...
"The signal has been important...
10/03/2025
Cath Lab Digest
Renal Denervation
Medtronic Receives Approval for Symplicity Spyral Renal Denervation System in Japan
09/02/2025
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure...
09/02/2025
Cath Lab Digest
RDN approvals
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
08/25/2025
The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is a...
08/25/2025
Cath Lab Digest
Guidelines
Recor Medical Responds to the American Heart Association (AHA) and American College of Cardiology’s (ACC) Updated Guidelines on Renal Denervation for the Treatment of Hypertension
08/15/2025
“We are pleased to see that the strength of our RADIANCE Global Program formed the basis for the positive inclusion in the guidelines, which not only reinforce the credibility of this therapy—they directly align with the compelling clinical...
“We are pleased to see that the strength of our RADIANCE Global Program formed the basis for the positive inclusion in the guidelines, which not only reinforce the credibility of this therapy—they directly align with the compelling clinical...
“We are pleased to see that the...
08/15/2025
Cath Lab Digest
BP Readings
Blood Pressure Cuff Errors May Be Missing 30% of Hypertension Cases
08/15/2025
08/15/2025
Cath Lab Digest
Guidelines
Medtronic Announces 2025 American College of Cardiology / American Heart Association Updated Hypertension Guidelines for Renal Denervation; Procedure Now Recommended
08/15/2025
The new ACC/AHA hypertension guidelines classify renal denervation procedures - like those using the Medtronic Symplicity Spyral™ renal denervation system - as a class IIb recommendation. These guidelines follow earlier consensus statements...
The new ACC/AHA hypertension guidelines classify renal denervation procedures - like those using the Medtronic Symplicity Spyral™ renal denervation system - as a class IIb recommendation. These guidelines follow earlier consensus statements...
The new ACC/AHA hypertension...
08/15/2025
Cath Lab Digest
Paradise (Recor Medical)
Renal Denervation
Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension
07/11/2025
The proposed National Coverage Determination (NCD), released on July 10, 2025, recommends coverage for ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rfRDN) for uncontrolled hypertension. A 30-day public comment...
The proposed National Coverage Determination (NCD), released on July 10, 2025, recommends coverage for ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rfRDN) for uncontrolled hypertension. A 30-day public comment...
The proposed National Coverage...
07/11/2025
Cath Lab Digest
Resistant Hypertension
First Patient Treated in Medtronic Multi-Organ SPYRAL GEMINI Pilot Study
07/07/2025
The first patient was treated by Dr. Barry Bertolet at Cardiology Associates of North Mississippi and North Mississippi Medical Center in Tupelo. With this trial, Medtronic intends to investigate the feasibility of combined denervation of...
The first patient was treated by Dr. Barry Bertolet at Cardiology Associates of North Mississippi and North Mississippi Medical Center in Tupelo. With this trial, Medtronic intends to investigate the feasibility of combined denervation of...
The first patient was treated by...
07/07/2025
Cath Lab Digest

Joachim Weil, MD
RF RDN
SPYRAL HTN-OFF and -ON MED 24-Month Results: BP Reductions After RF RDN
04/02/2025
Joachim Weil, MD
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a...
04/02/2025
Cath Lab Digest
Jeremy Bock, MD
Renal Denervation
Blood Pressure Response Following Radiofrequency Renal Denervation in a Large Commercial U.S. Cohort
03/21/2025
Jeremy S. Bock, MD, FACC, FSCAI
Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...
Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...
Dr. Jeremy Bock discusses his...
03/21/2025
Cath Lab Digest
Michael J. Bloch headshot
Meeting Update
Updates from TCT 2023: Renal Denervation
11/22/2023
Michael J. Bloch, MD
Michael J. Bloch, MD, discusses hypertension and a patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials.
Michael J. Bloch, MD, discusses hypertension and a patient-level pooled analysis of ultrasound renal denervation in the sham-controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO trials.
Michael J. Bloch, MD, discusses...
11/22/2023
Journal of Invasive Cardiology
Philips OBL / ASC Video
Brief Overview
Out-of-Hospital (OBL/ASC) Trends and Landscape
11/19/2025
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that...
11/19/2025
Cath Lab Digest
Interview With Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert
Videos
Prevalence of Atrial Fibrillation Increases Major Adverse Cardiovascular Events, Particularly Heart Failure Hospitalization in Patients With Peripheral Arterial Disease
11/18/2025
Viet Le, PA-C, FACC, FAHA; Isabel Vega
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS, PA-C, FACC, FAHA, HF-Cert, discusses his abstract from AHA 2025.
Watch as Viet Le, DMSc, MPAS,...
11/18/2025
EP Lab Digest
Ryan K. Kaple, MD, FACC, FSCAI
Heart Failure
CardioMEMS™ HF System in Structural Heart: Integrated Heart Failure Care with PA Pressure Monitoring
10/28/2025
Ryan Kaple, MD
In this video, Ryan K. Kaple, MD, FACC, FSCAI, discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this video, Ryan K. Kaple, MD, FACC, FSCAI, discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this video, Ryan K. Kaple,...
10/28/2025
Cath Lab Digest
PCI in ASCs
Video Discussion
PCI in ASCs: A Look at Patient Characteristics, Volume Trends, and Outcomes in the Medicare Population
10/03/2025
Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
A discussion of the study presented at SCAI's 2025 Annual Meeting, " Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population".
A discussion of the study presented at SCAI's 2025 Annual Meeting, " Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population".
A discussion of the study...
10/03/2025
Cath Lab Digest
Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS, with Morton J. Kern, MD, MSCAI, and Arnold H. Seto, MD, MPA
Kern, Seto, & Richardson
SCAI 2025: 4 Trials Under Discussion
09/26/2025
Bailey Ann Estes, AGNP-C, MSN, RN-BC, RCIS, RNFA; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
Join Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS, and Drs Morton Kern and Arnold Seto, in a SCAI 2025 discussion that highlights four trials across the interventional cardiology spectrum.
Join Bailey Ann Richardson, NP-C, RNFA, CNOR, RCIS, and Drs Morton Kern and Arnold Seto, in a SCAI 2025 discussion that highlights four trials across the interventional cardiology spectrum.
Join Bailey Ann Richardson,...
09/26/2025
Cath Lab Digest
Mike Watts, MD
AMP 2025
Will AI and Wearables Change the Future of CLTI Therapy?
09/18/2025
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses his presentation on the use of wearables and artificial intelligence in the prevention and treatment of chronic limb-threatening ischemia.
Mike Watts, MD, FSIR, discusses...
09/18/2025
Vascular Disease Management
Bailey Estes, NP, and Ahmad Alkhalil, MD
Structural Trials Discussion
New York Valves 2025: 4 Trials Under Discussion
08/05/2025
Bailey Ann Estes MSN, AGNP-C, RN-BC, RNFA, CNOR, RCIS; Ahmad Alkhalil, MD, MSc
Bailey Estes, MSN, AGNP, talks with Dr. Ahmad Alkhalil about four presented trials that were hotly anticipated at the CRF New York Valves Meeting, held June 24-26, 2025, in New York, New York.
Bailey Estes, MSN, AGNP, talks with Dr. Ahmad Alkhalil about four presented trials that were hotly anticipated at the CRF New York Valves Meeting, held June 24-26, 2025, in New York, New York.
Bailey Estes, MSN, AGNP, talks...
08/05/2025
Cath Lab Digest
Bailey Estes, Michelle Bierig, and Chris Steelman
PROFESSIONAL DEVELOPMENT
The American College of Cardiology's CV Team Allied Health Group: Calling All Cath Lab Team Members – Join Us!
06/12/2025
Bailey Estes, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS, talks with Co-Chairs of the ACC's Allied Health Work Group, Chris Steelman, MS, RT(R)(CI), RCIS, and Michelle Bierig, PhD, ACS, RCS, RDCS.
Bailey Estes, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS, talks with Co-Chairs of the ACC's Allied Health Work Group, Chris Steelman, MS, RT(R)(CI), RCIS, and Michelle Bierig, PhD, ACS, RCS, RDCS.
Bailey Estes, MSN, AGNP, RN-BC,...
06/12/2025
Cath Lab Digest
Robert M. Califf, MD
SCAI 2025
Robert M. Califf, MD, Shares His SCAI 2025 Keynote Summary
05/14/2025
Robert M. Califf, MD
In this 5-minute video, former U.S. FDA Commissioner Robert M. Califf, MD, discusses the American healthcare system and the current state of interventional cardiology. Dr. Califf presented the 2025 Society for Cardiovascular Angiography and...
In this 5-minute video, former U.S. FDA Commissioner Robert M. Califf, MD, discusses the American healthcare system and the current state of interventional cardiology. Dr. Califf presented the 2025 Society for Cardiovascular Angiography and...
In this 5-minute video, former...
05/14/2025
Cath Lab Digest
Jaafar Golzar, MD
Peripheral Intervention

PTAB With the DETOUR™ System: Treatment Options for Complex PAD Patients
05/08/2025
Jaafer A. Golzar, MD
"Percutaneous bypass has opened a new realm of possibilities for patient care," says Dr. Jaafer A. Golzar. Learn about Dr. Golzar's experience with the DETOUR System (Endologix). He also shares one of his first cases treated with PTAB.
"Percutaneous bypass has opened a new realm of possibilities for patient care," says Dr. Jaafer A. Golzar. Learn about Dr. Golzar's experience with the DETOUR System (Endologix). He also shares one of his first cases treated with PTAB.
"Percutaneous bypass has opened...
05/08/2025
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

ultrasound renal denervation
Latest Real-World Clinical Data Demonstrate a 19.6 mmHg Reduction in Blood Pressure at 6 Months with Recor Medical’s Paradise Ultrasound Renal Denervation System
10/30/2025
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE Clinical Trial Program Demonstrates a 15.7...
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months, and a Pooled Data Analysis from the RADIANCE Clinical Trial Program Demonstrates a 15.7...
Data Presented at the 2025 TCT...
10/30/2025
Cath Lab Digest
Renal Denervation
CMS Issues National Coverage Determination for Recor Medical’s Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
10/29/2025
Recor Medical, Inc., News Palo Alto, Calif. – Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that the Centers for Medicare and Medicaid Services (CMS) has issued its National Coverage...
Recor Medical, Inc., News Palo Alto, Calif. – Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that the Centers for Medicare and Medicaid Services (CMS) has issued its National Coverage...
Recor Medical, Inc.,...
10/29/2025
Cath Lab Digest
Renal Denervation
Medtronic Receives Approval for Symplicity Spyral Renal Denervation System in Japan
09/02/2025
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure procedure is an innovative, minimally invasive procedure that uses a single thin tube to deliver radiofrequency energy to calm the nerves near the kidneys that can become overactive and cause elevated blood...
The Symplicity blood pressure...
09/02/2025
Cath Lab Digest
RDN approvals
Recor Medical Announces Paradise Ultrasound Renal Denervation System Receives Manufacturing and Marketing Approval in Japan for the Treatment of Resistant Hypertension
08/25/2025
The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is a novel ultrasound-based renal denervation technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is a...
08/25/2025
Cath Lab Digest
Guidelines
Recor Medical Responds to the American Heart Association (AHA) and American College of Cardiology’s (ACC) Updated Guidelines on Renal Denervation for the Treatment of Hypertension
08/15/2025
“We are pleased to see that the strength of our RADIANCE Global Program formed the basis for the positive inclusion in the guidelines, which not only reinforce the credibility of this therapy—they directly align with the compelling clinical...
“We are pleased to see that the strength of our RADIANCE Global Program formed the basis for the positive inclusion in the guidelines, which not only reinforce the credibility of this therapy—they directly align with the compelling clinical...
“We are pleased to see that the...
08/15/2025
Cath Lab Digest
BP Readings
Blood Pressure Cuff Errors May Be Missing 30% of Hypertension Cases
08/15/2025
08/15/2025
Cath Lab Digest
Guidelines
Medtronic Announces 2025 American College of Cardiology / American Heart Association Updated Hypertension Guidelines for Renal Denervation; Procedure Now Recommended
08/15/2025
The new ACC/AHA hypertension guidelines classify renal denervation procedures - like those using the Medtronic Symplicity Spyral™ renal denervation system - as a class IIb recommendation. These guidelines follow earlier consensus statements...
The new ACC/AHA hypertension guidelines classify renal denervation procedures - like those using the Medtronic Symplicity Spyral™ renal denervation system - as a class IIb recommendation. These guidelines follow earlier consensus statements...
The new ACC/AHA hypertension...
08/15/2025
Cath Lab Digest
Paradise (Recor Medical)
Renal Denervation
Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension
07/11/2025
The proposed National Coverage Determination (NCD), released on July 10, 2025, recommends coverage for ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rfRDN) for uncontrolled hypertension. A 30-day public comment...
The proposed National Coverage Determination (NCD), released on July 10, 2025, recommends coverage for ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rfRDN) for uncontrolled hypertension. A 30-day public comment...
The proposed National Coverage...
07/11/2025
Cath Lab Digest
Resistant Hypertension
First Patient Treated in Medtronic Multi-Organ SPYRAL GEMINI Pilot Study
07/07/2025
The first patient was treated by Dr. Barry Bertolet at Cardiology Associates of North Mississippi and North Mississippi Medical Center in Tupelo. With this trial, Medtronic intends to investigate the feasibility of combined denervation of...
The first patient was treated by Dr. Barry Bertolet at Cardiology Associates of North Mississippi and North Mississippi Medical Center in Tupelo. With this trial, Medtronic intends to investigate the feasibility of combined denervation of...
The first patient was treated by...
07/07/2025
Cath Lab Digest
Symplicity Spyral renal denervation
Study
Medtronic Treats First U.S. Patient in Global SYMPLICITY Registry DEFINE Study
06/11/2025
The GSR-DEFINE study is a prospective, all-comer observational extension of the broader Global SYMPLICITY Registry - the largest real-world study evaluating the long-term safety and effectiveness of Medtronic’s renal denervation (RDN) systems...
The GSR-DEFINE study is a prospective, all-comer observational extension of the broader Global SYMPLICITY Registry - the largest real-world study evaluating the long-term safety and effectiveness of Medtronic’s renal denervation (RDN) systems...
The GSR-DEFINE study is a...
06/11/2025
Cath Lab Digest
thrombectomy
Penumbra Launches Lightning Flash 3.0 — The Next Evolution in CAVT Technology
01/27/2026
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the...
01/27/2026
Cath Lab Digest
AI Cardiac Imaging Software
Study Reveals Stark Disconnect Between Americans’ Desire for Preventive Cardiac Screening and Care They Can Access
01/27/2026
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to American Heart Health Month, a new national study reveals a stark disconnect between Americans’ desire for preventive cardiac screening and the care they can access. Despite heart disease remaining the leading...
New York, NY – In the lead-up to...
01/27/2026
Cath Lab Digest
Patent Foramen Ovale Detection
BURL Concepts Announces First Human Uses of FOQUS Ultrasound System for Patent Foramen Ovale (PFO) Detection
01/27/2026
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system, powered by SONAS technology, includes a transcranial headset system. The system introduces a new method to assist physicians in diagnosing a PFO, addressing the need for diagnostic tools that are both faster,...
The FOQUS ultrasound system,...
01/27/2026
Cath Lab Digest
AI Plaque analysis
Aetna Approves Coverage for Cleerly's AI Cardiovascular Imaging Analysis
01/21/2026
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER, CO – Cleerly, focused on AI-based cardiovascular imaging, announced that Aetna will begin covering Cleerly® LABS plaque analysis effective immediately. Aetna, which covers more than 20+ million lives,...
DENVER,...
01/21/2026
Cath Lab Digest
AI Plaque analysis
Coverage Unlocks Reimbursable AI Plaque Quantification With Circle Cardiovascular Imaging's cvi42|Plaque
01/21/2026
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle Cardiovascular Imaging Inc. (Circle CVI), focused on cardiovascular imaging post-processing, announced that clinical practices using its FDA 510(k)-cleared cvi42 with AI-enabled plaque...
CALGARY, Alberta -- Circle...
01/21/2026
Cath Lab Digest
Acquisitions
Haemonetics Acquires Vivasure Medical Limited
01/21/2026
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite system uses a proprietary bioabsorbable patch to seal large-bore (up to 26 F) arteriotomies and venotomies from inside the vessel, offering a sutureless, fully absorbable solution for structural heart and...
Vivasure's PerQseal® Elite...
01/21/2026
Cath Lab Digest
Early CAD Detection
Mammograms and Hidden Heart Disease: Annual Scans Can Detect This Silent Killer and Help Save Lives, but Awareness Is Key
01/21/2026
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast Arterial Calcification Trial at Mount Sinai,” doctors are sending letters to patients with high breast artery calcification levels, urging them to see a cardiologist or other doctor for further evaluation to...
In the “Mammography and Breast...
01/21/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Demonstrates Ability to Offer Interventional Physicians Unmatched Level of Radiation Protection Thanks to First-of-Its-Kind NOVARAD Clinical Study
01/21/2026
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD clinical study show that use of Nova-X® full-body, team-wide radiation protection system reduces dose received by main operator in interventional neuroradiology by a factor of eleven.
Final results of NOVARAD...
01/21/2026
Cath Lab Digest
Technology & Health Literacy
ECRI: Misuse of AI Chatbots Tops Annual List of Health Tech Hazards
01/21/2026
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots have suggested incorrect diagnoses, recommended unnecessary testing, promoted subpar medical supplies, and even invented body parts in response to medical questions while sounding like a trusted expert.
ECRI experts say that chatbots...
01/21/2026
Cath Lab Digest
CAD Risk Factors
North Carolina State University Study Finds Police-Related Stress Associated With Physical Markers of Cardiovascular Health Risk for Black Women
01/19/2026
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related Stress and Carotid Intima-Media Thickness Among African American Women,” is published in the journal Biopsychosocial Science and Medicine.
The paper, “Police-Related...
01/19/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use